Kyung Nam Pharm Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
32,757
36,014
39,087
39,758
39,714
Cost of Goods Sold (COGS) incl. D&A
16,953
18,364
18,986
21,514
21,389
Gross Income
15,804
17,649
20,101
18,244
18,325
SG&A Expense
17,343
13,899
13,704
12,351
14,143
EBIT
1,726
3,646
6,291
5,793
4,033
Unusual Expense
10,598
-
305
3,126
6,476
Non Operating Income/Expense
5,551
887
1,462
314
117
Interest Expense
2,802
2,144
1,609
1,059
1,147
Pretax Income
20,510
669
2,969
1,368
3,602
Income Tax
3,901
88
857
1,238
378
Consolidated Net Income
16,609
581
2,111
130
3,224
Net Income
16,609
581
2,111
130
3,224
Net Income After Extraordinaries
16,609
581
2,111
130
3,224
Net Income Available to Common
16,609
581
2,111
130
3,224
EPS (Basic)
1,695.00
58.00
189.00
12.00
287.00
Basic Shares Outstanding
10
10
11
11
11
EPS (Diluted)
1,693.87
57.92
189.32
11.54
286.62
Diluted Shares Outstanding
10
10
11
11
11
EBITDA
1,001
4,324
6,940
6,427
4,727
Other Operating Expense
186
104
106
100
149
Non-Operating Interest Income
166
53
53
74
105
About Kyung Nam Pharm Co.
View Profile
